Regulatory B cells in cancer
- 23 December 2020
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 299 (1), 74-92
- https://doi.org/10.1111/imr.12939
Abstract
Tumorigenesis proceeds through discrete steps where acquisition of genetic lesions and changes in the surrounding microenvironment combine to drive unrestricted neoplastic proliferation and metastasis. The ability of tumor‐infiltrating immune cells to promote tumor growth via the provision of signals that enable tumor cell survival and proliferation as well as contribute to immune suppression is an active area of research. Recent efforts have provided us with mechanistic insights into how B cells can positively and negatively regulate immune responses. Negative regulation of immune responses in cancer can be mediated by regulatory B cells and is often a result of increased production of cytokines that can directly and indirectly affect anti‐tumor immune function and cancer cell growth. Signals that lead to the expansion of regulatory B cells and the spectrum of their functional roles are not well understood and are the subject of active research by many groups. Here, we elaborate broadly on the history of regulatory B cells in cancer and summarize recent studies that have established genetic models for the study of regulatory B cell function and their potential for therapeutic intervention in the setting of solid cancers.Keywords
Funding Information
- National Cancer Institute (1F31CA239494‐01A1, R37 CA230786)
- Concern Foundation
- V Foundation for Cancer Research
This publication has 181 references indexed in Scilit:
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactionsNature, 2012
- Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant miceProceedings of the National Academy of Sciences of the United States of America, 2012
- Targeting CD20 in Melanoma Patients at High Risk of Disease RecurrenceMolecular Therapy, 2012
- The composition and signaling of the IL-35 receptor are unconventionalNature Immunology, 2012
- B cells and autoimmunityCurrent Opinion in Immunology, 2011
- Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent ColitisGastroenterology, 2011
- B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2011
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancerNature, 2010
- FcRγ Activation Regulates Inflammation-Associated Squamous CarcinogenesisCancer Cell, 2010
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008